FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dominick Angiolillo

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Devices

Stents

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Platelet function profiles in patients with diabetes mellitus.
Fernando Alfonso; Dominick J Angiolillo
Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damage.
Deepak L Bhatt; Ezio Bramucci; Dianne Gallup; Philippe Généreux; C Michael Gibson; Christian W Hamm; Robert A Harrington; Sergio Leonardi; Tiepu Liu; Kenneth W Mahaffey; Brent T McLaurin; Jayne Prats; Matthew J Price; Peter W Radke; Simona Skerjanec; Douglas Spriggs; P Gabriel Steg; Gregg W Stone; Jeffrey Tauth; Meredith Todd; Frantisek Tousek; Harvey D White; Petr Widimský; Dominick J Angiolillo
Effect of platelet inhibition with cangrelor during PCI on ischemic events.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dominick Angiolillo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Platelet function profiles in patients with diabetes mellitus.
Journal of cardiovascular translational research 2013;6(3):329-45.
2013: Fernando Alfonso; Dominick J Angiolillo
Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damage.
Journal of the American College of Cardiology 2013;61(20):2056-9.
2013: Deepak L Bhatt; Ezio Bramucci; Dianne Gallup; Philippe Généreux; C Michael Gibson; Christian W Hamm; Robert A Harrington; Sergio Leonardi; Tiepu Liu; Kenneth W Mahaffey; Brent T McLaurin; Jayne Prats; Matthew J Price; Peter W Radke; Simona Skerjanec; Douglas Spriggs; P Gabriel Steg; Gregg W Stone; Jeffrey Tauth; Meredith Todd; Frantisek Tousek; Harvey D White; Petr Widimský; Dominick J Angiolillo
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
The New England journal of medicine 2013;368(14):1303-13.
2013: Michael S Firstenberg; David R Holmes; Martin Hutyra; Tiepu Liu; Steven V Manoukian; Gilles Montalescot; Jayne Prats; Matthew Price; Chandrashekar Ramaiahm; Meredith Todd; Dominick J Angiolillo; Miroslav Brtko; Louis A Cannon; Harish Chandna; Nicholas Chronos; Markus Dietrich; Cornelius M Dyke; Pradyumna E Tummala; Michele Voeltz; Ian Welsby; Eric J Topo
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
The heart surgery forum 2013;16(2):E60-9.
2013: Hao-Jie Zhu; Xinwen Wang; Dominick J Angiolillo; Bryan J Brinda; Brian E Gawronski; John S Markowitz
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
The Journal of pharmacology and experimental therapeutics 2013;344(3):665-72.
2013: Payal Kohli; Gerald Maurer; Joao Morais; José C Nicolau; Ali Oto; Eric Reyes; Robert F Storey; Lars Wallentin; Dominick J Angiolillo; Diego Ardissino; Jay Horrow; Steen Husted; Stefan K James; Christopher P Cannon
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Circulation 2013;127(6):673-80.
2013: José Luis Ferreiro; Luis A Guzman; Fabiana Rollini; Naveen Seecheran; Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Theodore A Bass; Bhaloo Desai; Dominick J Angiolillo
Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.
JACC. Cardiovascular interventions 2013;6(2):182-4.
2013: Mario Leoncini; Mauro Maioli; Rossella Marcucci; Anna Toso; Rosanna Abbate; Dominick J Angiolillo; Betti Giusti; Francesco Bellandi
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
JACC. Cardiovascular interventions 2013;6(2):169-79.
2013: Dominick J Angiolillo; Fabiana Rollini
Switching from prasugrel to clopidogrel: navigating in unknown waters.
JACC. Cardiovascular interventions 2013;6(2):166-8.
2013: José L Ferreiro; Luis A Guzman; Fabiana Rollini; Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Theodore A Bass; Davide Capodanno; Piera Capranzano; Andrew Darlington; Bhaloo Desai; Kodlipet Dharmashankar; Dominick J Angiolillo
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
Journal of thrombosis and thrombolysis 2013;35(2):155-64.
2013: William E Boden; Alexandra Lansky; Dominick J Angiolillo
Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndrome.
The American journal of cardiology 2013;111(3):439-44.
2013: David Vivas; Dominick J Angiolillo; Esther Bernardo; Alfonso Calle-Pascual; Juan C Garcia-Rubira; Carlos Macaya; Patricia Martín; Ivan Nuñez Gil; Antonio Fernández-Ortiz
Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study ("Control de HIperglucemia y Actividad Plaquetaria en Pacientes con Síndrome Coronario Agudo").
Journal of thrombosis and thrombolysis 2013;35(2):165-74.
2013: Shahdad Azmoon; Dominick J Angiolillo
Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2013;81(2):232-42.
2013: Piera Capranzano; Andrew Darlington; Bhaloo Desai; Kodlipet Dharmashankar; Jose Luis Ferreiro; Fabiana Rollini; Antonio Tello-Montoliu; Masafumi Ueno; Davide Capodanno; Dominick J Angiolillo
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2013;81(1):42-9.
2012: David Erlinge; David Foley; Joseph A Jakubowski; Stefan James; Junxiang Luo; Brian Moser; David S Small; Jurrien Ten Berg; Henrik Wagner; Dominick J Angiolillo; Thomas Bergmeijer; Patricia B Brown; Chunmei Zhou; Kenneth J Winters
Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial.
Journal of the American College of Cardiology 2012;60(20):2032-40.
2012: Dominick J Angiolillo
The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.
Drugs 2012;72(16):2087-116.
2012: Siva Suryadevara; Antonio Tello-Montoliu; Masafumi Ueno; Martin Zenni; Theodore A Bass; Lyndon C Box; Bhaloo Desai; Jose Luis Ferreiro; Luis A Guzman; Fabiana Rollini; Dominick J Angiolillo
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.
Thrombosis and haemostasis 2012;108(5):930-6.
2012: Antonio Tello-Montoliu; Bhaloo Desai; Giuseppe Pasqualino; Ronakkumar Patel; Fabiana Rollini; Kjell S Sakariassen; Alexandra Santana Sorensen; Dominick J Angiolillo
Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.
Journal of thrombosis and thrombolysis 2012;34(3):297-9.
2012: Valentin Fuster; Dominick J Angiolillo; Eric R Bates; Deepak L Bhatt; Robert M Califf; David J Cohen; Barry S Coller; Bruce Furie; W Keith Hoots; Jean-Sebastien Hulot; Kenneth G Mann; Jessica L Mega; Alan D Michelson; Kiran Musunuru; Christopher J O'Donnell; Matthew J Price; Yves D Rosenberg; Marc S Sabatine; David J Schneider; Daniel I Simon; Jeffrey I Weitz; Marlene S Williams; Ahmed A K Hasan
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
Circulation 2012;126(13):1645-62.
2012: Dominick J Angiolillo; Davide Capodanno
Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitors.
Journal of the American College of Cardiology 2012;60(10):895-7.
2012: Giuseppe Musumeci; Michele Romano; Renato Rosiello; Roberta Rossini; Orazio Valsecchi; Davide Capodanno; Antonello Gavazzi; Giulio Guagliumi; Corrado Lettieri; Dominick J Angiolillo
Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;80(3):395-405.
2012: Fabiana Rollini; Antonio Tello-Montoliu; Dominick J Angiolillo
Atopaxar: a review of its mechanism of action and role in patients with coronary artery disease.
Future cardiology 2012;8(4):503-11.
2012: Roberta Rossini; Stefano Savonitto; Marino Scherillo; Daniela Trabattoni; Luigi Oltrona Visconti; Dominick J Angiolillo; Francesco Bovenzi; Ezio Bramucci; Francesca Buffoli; Battistina Castiglioni; Alberto Cremonesi; Stefano De Servi; Giulio Guagliumi; Corrado Lettieri; Maddalena Lettino; Giuseppe Musumeci; Emanuela Piccaluga
[Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
Giornale italiano di cardiologia (2006) 2012;13(7-8):528-51.
2012: Michelle L O'Donoghue; Fang Ren; Uwe Zeymer; Rafal Ziecina; Dominick J Angiolillo; Philip E Aylward; Deepak L Bhatt; Marcus D Flather; Shaun G Goodman; Shinya Goto; Hiroyuki Kobayashi; Gilles Montalescot; Stephen D Wiviott
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
Journal of thrombosis and thrombolysis 2012;34(1):36-43.
2012: Dominick J Angiolillo; Deepak L Bhatt; William J French; Robert A Harrington; Kurt Huber; Tiepu Liu; Jayne Prats; Matthew J Price; Jorge F Saucedo; David J Schneider; Tamaz Shaburishvili; Richard C Becker
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials.
Journal of thrombosis and thrombolysis 2012;34(1):44-55.
2012: Matthew J Price; James S Walder; Kenneth J Winters; Brian A Baker; Darell E Heiselman; Joseph A Jakubowski; Wei Li; Douglas K Logan; Dominick J Angiolillo
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
Journal of the American College of Cardiology 2012;59(25):2338-43.
2012: Dietmar Trenk; Gert Richardt; Gregg W Stone; Dominick J Angiolillo; Meinrad Gawaz; Joseph A Jakubowski; Adnan Kastrati; Ulrike Müller; Franz-Josef Neumann
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
Journal of the American College of Cardiology 2012;59(24):2159-64.
2012: José Luis Ferreiro; Dominick J Angiolillo
New directions in antiplatelet therapy.
Circulation. Cardiovascular interventions 2012;5(3):433-45.
2012: Robert C Welsh; Uwe Zeymer; Dominick J Angiolillo; Lisa G Berdan; Deepak L Bhatt; William J French; C Michael Gibson; Daniel D Gretler; Paul A Gurbel; Robert A Harrington; Kurt Huber; Janusz Kochman; Sergio Leonardi; Mina Madan; Matthew W McClure; Gayle Paynter; Sunil V Rao; Vivian P Thompson
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial.
Circulation. Cardiovascular interventions 2012;5(3):336-46.
2012: Dominick J Angiolillo; Samuel Broderick; Michael Buerke; Pamela B Conley; Marek Dabrowski; Paul A Gurbel; Robert A Harrington; Lisa K Jennings; Janusz Kochman; Matthew W McClure; Franz-Josef Neumann; Jorge F Saucedo; Gillian Stephens; Juergen Stumpf; Dietmar Trenk; Robert C Welsh; Jarosław Wójcik; Sunil V Rao
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial.
Circulation. Cardiovascular interventions 2012;5(3):347-56.
2012: Davide Capodanno; Dominick J Angiolillo
Antithrombotic therapy in patients with chronic kidney disease.
Circulation 2012;125(21):2649-61.
2012: Matthew J Price; Nicholas J Schork; Erin N Smith; Paul S Teirstein; Rebecca L Tisch; Eric J Topol; Dominick J Angiolillo; Elizabeth Lillie; Sarah S Murray
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study.
Journal of the American College of Cardiology 2012;59(22):1928-37.
2012: Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Martin Zenni; Theodore A Bass; Lyndon C Box; Ronald K Charlton; Bhaloo Desai; José Luis Ferreiro; Luis A Guzman; Murali Kodali; Naveen Seecheran; Dominick J Angiolillo
Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study.
Journal of the American College of Cardiology 2012;59(19):1681-7.
2012: Tracy Y Wang; Dominick J Angiolillo; Paul F Bray; Mary Cushman; Harold L Dauerman; Patricia A French; Marc S Sabatine; Susan S Smyth; Richard C Becker
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
Journal of the American College of Cardiology 2012;59(10):891-900.
2012: Masafumi Ueno; Theodore A Bass; Davide Capodanno; Piera Capranzano; Ronald K Charlton; Bhaloo Desai; Kodlipet Dharmashankar; José Luis Ferreiro; Murali Kodali; Antonio Tello-Montoliu; Salvatore D Tomasello; Dominick J Angiolillo
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
JACC. Cardiovascular interventions 2012;5(3):293-300.
2012: Shaun G Goodman; Robert A Harrington; Steen Husted; Stefan K James; Jan Kilhamn; Kenneth W Mahaffey; José C Nicolau; Karen S Pieper; P Gabriel Steg; Robert F Storey; Lars Wallentin; Dominick J Angiolillo; Christopher P Cannon; Warren Cantor; Robert Clare
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
Circulation 2012;125(8):978-86.
2012: Davide Capodanno; Dominick J Angiolillo
Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrums.
Current treatment options in cardiovascular medicine 2012;14(1):57-68.
2012: Dominick J Angiolillo; Miroslav Brtko; Louis Cannon; Harish Chandna; Cornelius Dyke; Michael S Firstenberg; Martin Hutyra; Tiepu Liu; Steven V Manoukian; Gilles Montalescot; Jayne Prats; Matthew J Price; Chandrashekhar Ramaiah; Eric J Topol; Pradyumna E Tummala; Michele D Voeltz; Ian J Welsby
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2012;307(3):265-74.
2012: Antonio Tello-Montoliu; Salvatore D Tomasello; Dominick J Angiolillo
Prasugrel.
Advances in cardiology 2012;47():39-63.
2012: Fabiana Rollini; Antonio Tello-Montoliu; Dominick J Angiolillo
Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease.
Platelets 2012;23(7):537-51.
2012: Jose Luis Ferreiro; Dominick J Angiolillo
Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
Current pharmaceutical design 2012;18(33):5273-93.
2012: A Tello-Montoliu; Mariano Valdés; Dominick J Angiolillo; E Jover; J Rivera; Francisco Marin
New perspectives in antiplatelet therapy.
Current medicinal chemistry 2012;19(3):406-27.
2012: Fabiana Rollini; Dominick J Angiolillo; Marco Cattaneo
[The GRAVITAS study].
Giornale italiano di cardiologia (2006) 2012;13(1):1-5.
2012: José L Ferreiro; Masafumi Ueno; Davide Capodanno; Piera Capranzano; Bhaloo Desai; Dominick J Angiolillo
Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus.
Revista española de cardiología (English ed.) 2012;65(1):105-6.
2011: Piera Capranzano; Lucia D'Urso; Eligio Miccichè; Claudia Tamburino; Dominick J Angiolillo; Valeria Calvi; Davide Capodanno; Corrado Tamburino
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity.
Thrombosis and haemostasis 2011;106(6):1149-57.
2011: Jessica L Mega; Alan D Michelson; Michael J Pencina; William J Rogers; Christian T Ruff; Benjamin M Scirica; Dominick J Angiolillo; Charles Contant; Andrew L Frelinger; Willibald Hochholzer; Steven Isserman; Dean J Kereiakes; Michael J Kluk; Janina A Longtine; Marc S Sabatine
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.
JAMA : the journal of the American Medical Association 2011;306(20):2221-8.
2011: Marco Roffi; Dominick J Angiolillo; A Pieter Kappetein
Current concepts on coronary revascularization in diabetic patients.
European heart journal 2011;32(22):2748-57.
2011: David P Faxon; David R Holmes; David J Moliterno; Richard C Becker; Peter B Berger; Deepak L Bhatt; John W Eikelboom; Dominick J Angiolillo
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.
Circulation. Cardiovascular interventions 2011;4(5):522-34.
2011: Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Dominick J Angiolillo
Antiplatelet therapy: thrombin receptor antagonists.
British journal of clinical pharmacology 2011;72(4):658-71.
2011: David P Faxon; David R Holmes; David J Moliterno; Richard C Becker; Peter B Berger; Deepak L Bhatt; John W Eikelboom; Dominick J Angiolillo
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.
Thrombosis and haemostasis 2011;106(4):572-84.
2011: David Vivas; Dominick J Angiolillo; Luis Azcona; Esther Bernardo; Juan C Garcia-Rubira; Juan Jose González-Ferrer; Carlos Macaya; Ivan Nuñez Gil; Antonio Fernández-Ortiz
Can resistance to aspirin be reversed after an additional dose?
Journal of thrombosis and thrombolysis 2011;32(3):356-61.
2011: Dominick J Angiolillo
Applying platelet function testing in clinical practice: what are the unmet needs?
JAMA : the journal of the American Medical Association 2011;306(11):1260-1.
2011: John-Paul Pham; Naveen Seecheran; Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Theodore A Bass; Davide Capodanno; Bhaloo Desai; Kodlipet Dharmashankar; José Luis Ferreiro; Murali Kodali; Dominick J Angiolillo
Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study.
Journal of the American College of Cardiology 2011;58(13):1396-8.
2011: Matthew J Price; Jean-François Tanguay; Paul S Teirstein; Dominick J Angiolillo; Peter B Berger; Christopher P Cannon; Elizabeth Lillie; Steven V Manoukian; Eric J Topol
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial.
Circulation 2011;124(10):1132-7.
2011: Giuseppe Biondi-Zoccai; Fiorenzo Gaita; Marzia Lotrionte; Enrico Romagnoli; Giuseppe Sangiorgi; Antonio Abbate; Pierfrancesco Agostoni; Dominick J Angiolillo; Luca Testa; Marco Valgimigli; Imad Sheiban
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes.
International journal of cardiology 2011;150(3):325-31.
2011: Kenneth W Mahaffey; Karen S Pieper; Robert F Storey; Lars Wallentin; Daniel M Wojdyla; Dominick J Angiolillo; Richard C Becker; Christopher P Cannon; Kevin Carroll; Robert A Harrington; Claes Held; Jay Horrow; Stefan James
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Circulation 2011;124(5):544-54.
2011: Masafumi Ueno; Theodore A Bass; Davide Capodanno; Ronald K Charlton; Bhaloo Desai; Kodlipet Dharmashankar; José L Ferreiro; Murali Kodali; Naveen Seecheran; Antonio Tello-Montoliu; Salvatore D Tomasello; Dominick J Angiolillo
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
JACC. Cardiovascular interventions 2011;4(8):905-12.
2011: Andrew Darlington; Bhaloo Desai; José Luis Ferreiro; N Stanley Nahman; Yoshi Suzuki; Antonio Tello-Montoliu; Masafumi Ueno; Theodore A Bass; Davide Capodanno; Piera Capranzano; Dominick J Angiolillo
Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease.
Thrombosis and haemostasis 2011;106(1):67-74.
2011: Pilar Jiménez-Quevedo; Carlos Macaya; Nobuaki Suzuki; Fernando Alfonso; Dominick J Angiolillo; Camino Bañuelos; Theodore Bass; Cecilia Corros; Marco Costa; Javier Escaned; Cristina Fernández; María Cruz Ferrer; Nieves Gonzalo; Rosana Hernández-Antolín; Manel Sabaté
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study].
Revista española de cardiología 2011;64(7):557-63.
2011: Dominick J Angiolillo; Theodore A Bass; Esther Bernardo; Davide Capodanno; Piera Capranzano; Antonio Fernandez-Ortiz; Jose L Ferreiro; Pilar Jimenez-Quevedo; Giovanni Malerba; Alessandra Pasquali; Pier Franco Pignatti; Paola Prandini; Manel Sabaté; Elisabetta Trabetti; Masafumi Ueno; David Vivas; Martina Zanoni; Carlos Macaya
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Journal of the American College of Cardiology 2011;58(1):30-9.
2011: Dominick J Angiolillo
Unraveling myths of platelet function and genetic testing the road to making tailored antiplatelet therapy a reality.
Journal of the American College of Cardiology 2011;57(25):2484-6.
2011: Dominick J Angiolillo; Marco Roffi; Antonio Fernandez-Ortiz
Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.
Expert review of cardiovascular therapy 2011;9(6):697-710.
2011: José Luis Ferreiro; Murali K Kodali; John-Paul Pham; Naveen Seecheran; Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Theodore A Bass; Davide Capodanno; Ronald K Charlton; Andrew Darlington; Bhaloo Desai; Kodlipet Dharmashankar; Dominick J Angiolillo
Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study.
Circulation. Cardiovascular interventions 2011;4(3):273-9.
2011: Michelle L O'Donoghue; Stephen D Wiviott; Uwe Zeymer; Rafal Ziecina; Dominick J Angiolillo; Philip E Aylward; Deepak L Bhatt; Charles F Contant; Dariusz Dudek; Desmond J Fitzgerald; Marcus D Flather; Shaun G Goodman; Shinya Goto; Victor Guetta; Gilles Montalescot
Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.
Circulation 2011;123(17):1843-53.
2011: Stephen D Wiviott; Dominick J Angiolillo; Philip Aylward; Deepak L Bhatt; Charles F Contant; Fernando Cura; Dariusz Dudek; Desmond J Fitzgerald; Marcus D Flather; Shinya Goto; Victor Guetta; Michelle L O'Donoghue
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial.
Circulation 2011;123(17):1854-63.
2011: Antonio Tello-Montoliu; Masafumi Ueno; Dominick J Angiolillo
Antiplatelet drug therapy: role of pharmacodynamic and genetic testing.
Future cardiology 2011;7(3):381-402.
2011: David Vivas; Juan C Garcia-Rubira; Esther Bernardo; Dominick J Angiolillo; Patricia Martín; Alfonso Calle-Pascual; Ivan Nuñez Gil; Carlos Macaya; Antonio Fernández-Ortiz
Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo").
Heart (British Cardiac Society) 2011;97(10):803-9.
2011: Dominick J Angiolillo; Masafumi Ueno
Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations.
JACC. Cardiovascular interventions 2011;4(4):411-4.
2011: Davide Capodanno; Aasita Patel; Kodlipet Dharmashankar; José Luis Ferreiro; Masafumi Ueno; Murali Kodali; Salvatore D Tomasello; Piera Capranzano; Naveen Seecheran; Andrew Darlington; Antonio Tello-Montoliu; Bhaloo Desai; Theodore A Bass; Dominick J Angiolillo
Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
Circulation. Cardiovascular interventions 2011;4(2):180-7.
2011: Dominick J Angiolillo; Juan Jose Badimon; Jorge F Saucedo; Andrew L Frelinger; Alan D Michelson; Joseph A Jakubowski; Baojin Zhu; Clement K Ojeh; Brian A Baker; Mark B Effron
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial.
European heart journal 2011;32(7):838-46.
2011: Masafumi Ueno; José L Ferreiro; Salvatore D Tomasello; Davide Capodanno; Antonio Tello-Montoliu; Murali Kodali; Naveen Seecheran; Kodlipet Dharmashankar; Rana Alissa; Piera Capranzano; Bhaloo Desai; Ronald K Charlton; Theodore A Bass; Dominick J Angiolillo
Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease.
Thrombosis and haemostasis 2011;105(4):730-2.
2011: Matthew J Price; Peter B Berger; Paul S Teirstein; Jean-François Tanguay; Dominick J Angiolillo; Douglas Spriggs; Sanjeev Puri; Mark Robbins; Kirk N Garratt; Olivier F Bertrand; Michael E Stillabower; Michael E Stillablower; Joseph R Aragon; David E Kandzari; Curtiss T Stinis; Michael S Lee; Steven V Manoukian; Christopher P Cannon; Nicholas J Schork; Eric J Topol
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.
JAMA : the journal of the American Medical Association 2011;305(11):1097-105.
2011: Eric R Bates; Wei C Lau; Dominick J Angiolillo
Clopidogrel-drug interactions.
Journal of the American College of Cardiology 2011;57(11):1251-63.
2011: Davide Capodanno; Dominick J Angiolillo; Corrado Tamburino
[Antiplatelet and anticoagulant therapy in elderly patients].
Giornale italiano di cardiologia (2006) 2011;12(3):186-97.
2011: José Luis Ferreiro; Dominick J Angiolillo
Diabetes and antiplatelet therapy in acute coronary syndrome.
Circulation 2011;123(7):798-813.
2011: Roberta Rossini; Davide Capodanno; Corrado Lettieri; Giuseppe Musumeci; Tamar Nijaradze; Michele Romano; Nikoloz Lortkipanidze; Nicola Cicorella; Giuseppe Biondi Zoccai; Vasile Sirbu; Antonio Izzo; Giulio Guagliumi; Orazio Valsecchi; Antonello Gavazzi; Dominick J Angiolillo
Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation.
The American journal of cardiology 2011;107(2):186-94.
2011: Masafumi Ueno; Murali Kodali; Antonio Tello-Montoliu; Dominick J Angiolillo
Role of platelets and antiplatelet therapy in cardiovascular disease.
Journal of atherosclerosis and thrombosis 2011;18(6):431-42.
2011: Salvatore D Tomasello; Antonio Tello-Montoliu; Dominick J Angiolillo
Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development.
Expert opinion on investigational drugs 2011;20(1):119-33.
2011: Dominick J Angiolillo; C M Gibson; S Cheng; C Ollier; O Nicolas; L Bergougnan; L Perrin; F P LaCreta; F Hurbin; M Dubar
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.
Clinical pharmacology and therapeutics 2011;89(1):65-74.
2010: Salvatore Davide Tomasello; Dominick J Angiolillo; Shinya Goto
Inhibiting PAR-1 in the prevention and treatment of atherothrombotic events.
Expert opinion on investigational drugs 2010;19(12):1557-67.
2010: Stefan James; Dominick J Angiolillo; Jan H Cornel; David Erlinge; Steen E Husted; Fredrik Kontny; Juan Maya; Josë C Nicolau; Jindrich Spinar; Robert F Storey; Susanna R Stevens; Lars Wallentin
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.
European heart journal 2010;31(24):3006-16.
2010: José Luis Ferreiro; Joan Antoni Gómez-Hospital; Angel R Cequier; Dominick J Angiolillo; Gerard Roura; Luis Teruel; Jaume Maristany; Josep Gómez-Lara; Francesc Jara; Theodore A Bass; Enric Esplugas
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.
International journal of cardiology 2010;145(2):235-7.
2010: Davide Capodanno; Dominick J Angiolillo
Antithrombotic therapy in the elderly.
Journal of the American College of Cardiology 2010;56(21):1683-92.
2010: Victor L Serebruany; Mohamed El Mouelhi; Hans-Jürgen Pfannkuche; Kristine Rose; Martin Marro; Dominick J Angiolillo
Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
American journal of therapeutics 2010;17(6):543-52.
2010: Robert F Storey; Dominick J Angiolillo; Shankar B Patil; Bhaloo Desai; Rosemary Ecob; Steen Husted; Håkan Emanuelsson; Christopher P Cannon; Richard C Becker; Lars Wallentin
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
Journal of the American College of Cardiology 2010;56(18):1456-62.
2010: José Luis Ferreiro; Angel R Cequier; Dominick J Angiolillo
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.
Trends in cardiovascular medicine 2010;20(7):211-7.
2010: José Luis Ferreiro; Ángel R Cequier; Dominick J Angiolillo
Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2010;7(4):274-88.
2010: José Luis Ferreiro; Joan Antoni Gómez-Hospital; Dominick J Angiolillo
Platelet abnormalities in diabetes mellitus.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2010;7(4):251-9.
2010: José L Ferreiro; Masafumi Ueno; Davide Capodanno; Bhaloo Desai; Kodlipet Dharmashankar; Andrew Darlington; Ronald K Charlton; Theodore A Bass; Dominick J Angiolillo
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study.
Circulation. Cardiovascular interventions 2010;3(5):436-41.
2010: Dominick J Angiolillo; Jorge F Saucedo; Roger Deraad; Andrew L Frelinger; Paul A Gurbel; Timothy M Costigan; Joseph A Jakubowski; Clement K Ojeh; Mark B Effron
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study.
Journal of the American College of Cardiology 2010;56(13):1017-23.
2010: Laurent Bonello; Udaya S Tantry; Rossella Marcucci; Ruediger Blindt; Dominick J Angiolillo; Richard Becker; Deepak L Bhatt; Marco Cattaneo; Jean Philippe Collet; Thomas Cuisset; Christian Gachet; Gilles Montalescot; Lisa K Jennings; Dean Kereiakes; Dirk Sibbing; Dietmar Trenk; Jochem W van Werkum; Franck Paganelli; Matthew J Price; Ron Waksman; Paul A Gurbel
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
Journal of the American College of Cardiology 2010;56(12):919-33.
2010: Davide Capodanno; Dominick J Angiolillo
Impact of race and gender on antithrombotic therapy.
Thrombosis and haemostasis 2010;104(3):471-84.
2010: Masafumi Ueno; José Luis Ferreiro; Dominick J Angiolillo
Mechanism of action and clinical development of platelet thrombin receptor antagonists.
Expert review of cardiovascular therapy 2010;8(8):1191-200.
2010: Masafumi Ueno; José Luis Ferreiro; Dominick J Angiolillo
Update on the clinical development of cangrelor.
Expert review of cardiovascular therapy 2010;8(8):1069-77.
2010: Masafumi Ueno; Sunil V Rao; Dominick J Angiolillo
Elinogrel: pharmacological principles, preclinical and early phase clinical testing.
Future cardiology 2010;6(4):445-53.
2010: José Luis Ferreiro; Dirk Sibbing; Dominick J Angiolillo
Platelet function testing and risk of bleeding complications.
Thrombosis and haemostasis 2010;103(6):1128-35.
2010: Dominick J Angiolillo
Antithrombotic management in patients undergoing coronary stent implantation requiring chronic oral anticoagulation: how to balance safety and efficacy?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(6):943-5.
2010: Davide Capodanno; Dominick J Angiolillo
Diabetes mellitus: the scary killer haunting silently.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2010;5(8):879-81.
2010: Dominick J Angiolillo; Masafumi Ueno; Shinya Goto
Basic principles of platelet biology and clinical implications.
Circulation journal : official journal of the Japanese Circulation Society 2010;74(4):597-607.
2010: Dominick J Angiolillo; Esther Bernardo; Davide Capodanno; David Vivas; Manel Sabaté; José Luis Ferreiro; Masafumi Ueno; Pilar Jimenez-Quevedo; Fernando Alfonso; Theodore A Bass; Carlos Macaya; Antonio Fernandez-Ortiz
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
Journal of the American College of Cardiology 2010;55(11):1139-46.
2010: Davide Capodanno; Kodlipet Dharmashankar; Dominick J Angiolillo
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist.
Expert review of cardiovascular therapy 2010;8(2):151-8.
2010: David Vivas; Dominick J Angiolillo
Platelet P2Y₁₂ receptor inhibition: an update on clinical drug development.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2010;10(4):217-26.
2010: Dominick J Angiolillo; José Luis Ferreiro
Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions.
Revista española de cardiología 2010;63(1):60-76.
2010: Dominick J Angiolillo; Davide Capodanno; Shinya Goto
Platelet thrombin receptor antagonism and atherothrombosis.
European heart journal 2010;31(1):17-28.
2009: Robert A Harrington; Gregg W Stone; Steven McNulty; Harvey D White; A Michael Lincoff; C Michael Gibson; Charles V Pollack; Gilles Montalescot; Kenneth W Mahaffey; Neal S Kleiman; Shaun G Goodman; Maged Amine; Dominick J Angiolillo; Richard C Becker; Derek P Chew; William J French; Franz Leisch; Keyur H Parikh; Simona Skerjanec; Deepak L Bhatt
Platelet inhibition with cangrelor in patients undergoing PCI.
The New England journal of medicine 2009;361(24):2318-29.
2009: David E Kandzari; Dominick J Angiolillo; Matthew J Price; Paul S Teirstein
Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.
JACC. Cardiovascular interventions 2009;2(12):1279-85.
2009: D Capodanno; Dominick J Angiolillo
Platelet monitoring for PCI: which test is the one to choose?
Hämostaseologie 2009;29(4):376-80.
2009: Javier Escaned; Alex Flores; Pablo García-Pavía; Javier Segovia; Jesús Jimenez; Paloma Aragoncillo; Clara Salas; Fernando Alfonso; Rosana Hernández; Dominick J Angiolillo; Pilar Jiménez-Quevedo; Camino Bañuelos; Luis Alonso-Pulpón; Carlos Macaya
Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts.
Circulation 2009;120(16):1561-8.
2009: José Luis Ferreiro; Masafumi Ueno; Dominick J Angiolillo
Cangrelor: a review on its mechanism of action and clinical development.
Expert review of cardiovascular therapy 2009;7(10):1195-201.
2009: Francisco Marín; Rocío González-Conejero; Piera Capranzano; Theodore A Bass; Vanessa Roldán; Dominick J Angiolillo
Pharmacogenetics in cardiovascular antithrombotic therapy.
Journal of the American College of Cardiology 2009;54(12):1041-57.
2009: José Luis Ferreiro; Dominick J Angiolillo
Clopidogrel response variability: current status and future directions.
Thrombosis and haemostasis 2009;102(1):7-14.
2009: Alan D Michelson; Andrew L Frelinger; Eugene Braunwald; William E Downey; Dominick J Angiolillo; Nicholas P Xenopoulos; Joseph A Jakubowski; Youfu Li; Sabina A Murphy; Jie Qin; Carolyn H McCabe; Elliott M Antman; Stephen D Wiviott
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
European heart journal 2009;30(14):1753-63.
2009: Dominick J Angiolillo; Piera Capranzano; Bhaloo Desai; Steven Shoemaker; Ronald Charlton; Martin Zenni; Luis A Guzman; Theodore A Bass
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
Thrombosis research 2009;124(3):318-22.
2009: Marco Valgimigli; Gianluca Campo; Nicoletta de Cesare; Emanuele Meliga; Pascal Vranckx; Alessandro Furgieri; Dominick J Angiolillo; Manel Sabatè; Martial Hamon; Alessandra Repetto; Salvatore Colangelo; Salvatore Brugaletta; Giovanni Parrinello; Gianfranco Percoco; Roberto Ferrari
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation 2009;119(25):3215-22.
2009: Dominick J Angiolillo; Siva Suryadevara
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus.
Best practice & research. Clinical endocrinology & metabolism 2009;23(3):375-88.
2009: José Luis Ferreiro; Dominick J Angiolillo
Antiplatelet therapy: Clopidogrel plus PPIs-a dangerous combination?
Nature reviews. Cardiology 2009;6(6):392-4.
2009: Nobuaki Suzuki; Dominick J Angiolillo; Mark A Tannenbaum; Mitchell H Driesman; Conrad Smith; Mahesh Bikkina; Clyde R Meckel; Carlos E Morales; Nicholaos P Xenopoulos; John E Coletta; Hiram G Bezerra; Theodore A Bass; Marco A Costa
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(7):890-7.
2009: Davide Capodanno; Dominick J Angiolillo
Contemporary issues on clopidogrel therapy: a critical appraisal.
Internal and emergency medicine 2009;4(3):195-8.
2009: Matthew J Price; Peter B Berger; Dominick J Angiolillo; Paul S Teirstein; Jean-François Tanguay; David E Kandzari; Christopher P Cannon; Eric J Topol
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.
American heart journal 2009;157(5):818-24, 824.e1.
2009: Piera Capranzano; Jose Luis Ferreiro; Dominick J Angiolillo
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.
Expert review of cardiovascular therapy 2009;7(4):361-9.
2009: Dominick J Angiolillo
Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.
Diabetes care 2009;32(4):531-40.
2009: Corrado Tamburino; Dominick J Angiolillo; Piera Capranzano; Marilena Di Salvo; Gian Paolo Ussia; Alessio La Manna; Luis A Guzman; Alfredo R Galassi; Theodore A Bass
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(3):291-8.
2009: Dominick J Angiolillo; Deepak L Bhatt; Paul A Gurbel; Lisa K Jennings
Advances in antiplatelet therapy: agents in clinical development.
The American journal of cardiology 2009;103(3 Suppl):40A-51A.
2009: Dominick J Angiolillo
Variability in responsiveness to oral antiplatelet therapy.
The American journal of cardiology 2009;103(3 Suppl):27A-34A.
2009: Dominick J Angiolillo
Emerging insights on antiplatelet therapy. Introduction.
The American journal of cardiology 2009;103(3 Suppl):1A-3A.
2009: Dominick J Angiolillo
Platelet function testing in clinical practice: are we ready for prime time?
Revista española de cardiología 2009;62(2):113-6.
2009: Luigi M Biasucci; Giovanna Liuzzo; Roberta Della Bona; Milena Leo; Gina Biasillo; Dominick J Angiolillo; Antonio Abbate; Vittoria Rizzello; Giampaolo Niccoli; Simona Giubilato; Filippo Crea
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes.
Clinical chemistry 2009;55(2):365-8.
2009: Clarissa Cola; Salvatore Brugaletta; Victoria Martín Yuste; Bieito Campos; Dominick J Angiolillo; Manel Sabaté
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.
Vascular health and risk management 2009;5(1):101-19.
2009: Pilar Jiménez-Quevedo; Nobuaki Suzuki; Cecilia Corros; Cruz Ferrer; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Camino Bañuelos; Javier Escaned; Cristina Fernández; Marco Costa; Carlos Macaya; Theodore A Bass; Manel Sabaté
Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis.
Diabetes 2009;58(1):209-14.
2008: Roberta Rossini; Giuseppe Musumeci; Corrado Lettieri; Maria Molfese; Laurian Mihalcsik; Paola Mantovani; Vasile Sirbu; Theodore A Bass; Francesco Della Rovere; Antonello Gavazzi; Dominick J Angiolillo
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
The American journal of cardiology 2008;102(12):1618-23.
2008: Nobuaki Suzuki; Dominick J Angiolillo; Carmela Monteiro; Sania Shuja; Hideki Futamatsu; Ren Kawaguchi; Lyndon C Box; Luis Guzman; Martin M Zenni; Paul S Gilmore; Theodore A Bass; Marco A Costa
Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents.
International journal of cardiology 2008;130(3):444-8.
2008: Dominick J Angiolillo; Siva Suryadevara; Piera Capranzano; Theodore A Bass
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development.
Expert opinion on pharmacotherapy 2008;9(16):2893-900.
2008: Stephen D Wiviott; Eugene Braunwald; Dominick J Angiolillo; Simha Meisel; Anthony J Dalby; Freek W A Verheugt; Shaun G Goodman; Ramon Corbalan; Drew A Purdy; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation 2008;118(16):1626-36.
2008: Corrado Tamburino; Dominick J Angiolillo; Piera Capranzano; Konstantinos Dimopoulos; Alessio La Manna; Rossella Barbagallo; Francesco Tagliareni; Sarah Mangiafico; Luis A Guzman; Alfredo R Galassi; Theodore A Bass
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;72(4):448-56.
2008: Erik R Carlson; Robert F Percy; Dominick J Angiolillo; Donald A Conetta
Prognostic significance of troponin T elevation in patients without chest pain.
The American journal of cardiology 2008;102(6):668-71.
2008: Dominick J Angiolillo; Piera Capranzano; Shinya Goto; Mohammed Aslam; Bhaloo Desai; Ronald K Charlton; Yoshie Suzuki; Lyndon C Box; Steven B Shoemaker; Martin M Zenni; Luis A Guzman; Theodore A Bass
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
European heart journal 2008;29(18):2202-11.
2008: Dominick J Angiolillo; Luis A Guzman
Clinical overview of promising nonthienopyridine antiplatelet agents.
American heart journal 2008;156(2 Suppl):S23-8.
2008: Dominick J Angiolillo; Eric R Bates; Theodore A Bass
Clinical profile of prasugrel, a novel thienopyridine.
American heart journal 2008;156(2 Suppl):S16-22.
2008: Dominick J Angiolillo; Piera Capranzano
Pharmacology of emerging novel platelet inhibitors.
American heart journal 2008;156(2 Suppl):S10-5.
2008: Dominick J Angiolillo; Luis A Guzman; Theodore A Bass
Current antiplatelet therapies: benefits and limitations.
American heart journal 2008;156(2 Suppl):S3-9.
2008: Dominick J Angiolillo; Eric R Bates
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.
American heart journal 2008;156(2 Suppl):S1-2.
2008: Marco Valgimigli; Gianluca Campo; Nicoletta de Cesare; Pascal Vranckx; Martial Hamon; Dominick J Angiolillo; Manel Sabatè; Fabrizio Ferrari; Alessandro Furgieri; Carlo Tumscitz; Alessandra Repetto; Salvatore Colangelo; Emanuele Meliga; Moh'd Kubbajeh; Giovanni Parrinello; Gianfranco Percoco; Roberto Ferrari
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):313-20.
2008: Marco A Costa; Dominick J Angiolillo; Mark Tannenbaum; Mitchell Driesman; Alan Chu; John Patterson; William Kuehl; Joseph Battaglia; Samir Dabbons; Fayez Shamoon; Bruce Flieshman; Alan Niederman; Theodore A Bass
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
The American journal of cardiology 2008;101(12):1704-11.
2008: Yuji Oikawa; Junji Yajima; Dominick J Angiolillo; Masafumi Akabane; Ryuichi Funada; Shunsuke Matsuno; Toshiro Inaba; Yuya Nakagawa; Michinari Nakamura; Hitoshi Sawada; Tadanori Aizawa
Short- or long-term outcomes of coronary artery aneurysms occurring after directional coronary atherectomy.
The Journal of invasive cardiology 2008;20(4):159-60.
2008: Nobuaki Suzuki; Hitesh Nanda; Dominick J Angiolillo; Hiran Bezerra; Manel Sabaté; Pilar Jiménez-Quevedo; Fernando Alfonso; Carlos Macaya; Theodore A Bass; Olusegun J Ilegbusi; Marco A Costa
Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus.
The international journal of cardiovascular imaging 2008;24(4):357-64.
2008: Roberta Rossini; Dominick J Angiolillo; Giuseppe Musumeci; PierMario Scuri; Paolo Invernizzi; Theodore A Bass; Laurian Mihalcsik; Antonello Gavazzi
Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
The American journal of cardiology 2008;101(6):786-9.
2008: Hideki Futamatsu; Chris Klassen; Marco Pilla; norbert wilke; Dominick J Angiolillo; Stuart Smalheiser; Alan Siuciak; Nobuaki Suzuki; Theodore A Bass; Marco A Costa
Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography.
The international journal of cardiovascular imaging 2008;24(3):293-9.
2008: Dominick J Angiolillo; Marco A Costa; Steven Shoemaker; Bhaloo Desai; Esther Bernardo; Yoshie Suzuki; Ronald K Charlton; Martin Zenni; Luis A Guzman; Theodore A Bass
Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
The American journal of cardiology 2008;101(4):440-5.
2008: Luis A Guzman; Marco A Costa; Dominick J Angiolillo; Martin Zenni; Peter Wludyka; Scott L Silliman; Theodore A Bass
A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery.
Stroke; a journal of cerebral circulation 2008;39(2):361-5.
2008: R Kawaguchi; Manel Sabate; Dominick J Angiolillo; Pilar Jimenez-Quevedo; Nobuaki Suzuki; Cecilia Corros; Hideki Futamatsu; Fernando Alfonso; Rosana Hernandez-Antolin; Carlos Macaya; Theodore A Bass; Marco A Costa
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
The international journal of cardiovascular imaging 2008;24(2):125-32.
2008: Nader Antonios; Dominick J Angiolillo; Scott Silliman
Hypertriglyceridemia and ischemic stroke.
European neurology 2008;60(6):269-78.
2008: Dominick J Angiolillo; Esther Bernardo; Jorge Palazuelos; Bhaloo Desai; Ian Weisberg; Fernando Alfonso; Luis A Guzman; Rosana Hernández-Antolin; Martin Z Zenni; Carlos Macaya; Antonio Fernandez-Ortiz; Theodore A Bass
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Thrombosis and haemostasis 2008;99(1):161-8.
2007: Stephen D Wiviott; Dietmar Trenk; Andrew L Frelinger; Michelle O'Donoghue; Franz-Josef Neumann; Alan D Michelson; Dominick J Angiolillo; Hanoch Hod; Gilles Montalescot; Debra L Miller; Joseph A Jakubowski; Richard Cairns; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Circulation 2007;116(25):2923-32.
2007: Fernando Alfonso; Alfonso Suárez; María J Pérez-Vizcayno; Raul Moreno; Javier Escaned; Camino Bañuelos; Pilar Jiménez; Esther Bernardo; Dominick J Angiolillo; Rosana Hernández; Carlos Macaya
Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis.
Journal of the American College of Cardiology 2007;50(21):2095-7.
2007: Dominick J Angiolillo; Esther Bernardo; Manel Sabaté; Pilar Jimenez-Quevedo; Marco A Costa; Jorge Palazuelos; Rosana Hernández-Antolin; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Luis A Guzman; Theodore A Bass; Carlos Macaya; Antonio Fernandez-Ortiz
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Journal of the American College of Cardiology 2007;50(16):1541-7.
2007: Marzia Lotrionte; Giuseppe G L Biondi-Zoccai; Pierfrancesco Agostoni; Antonio Abbate; Dominick J Angiolillo; Marco Valgimigli; Claudio Moretti; Emanuele Meliga; Thomas Cuisset; Marie-Christine Alessi; Gilles Montalescot; Jean-Philippe Collet; Germano Di Sciascio; Ron Waksman; Luca Testa; Giuseppe Sangiorgi; Antonio Laudito; Gian Paolo Trevi; Imad Sheiban
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
The American journal of cardiology 2007;100(8):1199-206.
2007: Dominick J Angiolillo; Fernando Alfonso
Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure.
Thrombosis and haemostasis 2007;98(4):707-9.
2007: Lyndon C Box; Dominick J Angiolillo; Nobuaki Suzuki; Lesleigh A Box; Julie Jiang; Luis A Guzman; Martin A Zenni; Theodore A Bass; Marco A Costa
Heterogeneity of atherosclerotic plaque characteristics in human coronary artery disease: a three-dimensional intravascular ultrasound study.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;70(3):349-56.
2007: Marco A Costa; Steven Shoemaker; Hideki Futamatsu; Chris Klassen; Dominick J Angiolillo; Minh Nguyen; Alan Siuciak; Paul Gilmore; Martin Zenni; Luis A Guzman; Theodore A Bass; norbert wilke
Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve.
Journal of the American College of Cardiology 2007;50(6):514-22.
2007: Hideki Futamatsu; norbert wilke; Chris Klassen; Steven Shoemaker; Dominick J Angiolillo; Alan Siuciak; Kino Morikawa-Futamatsu; Nobuaki Suzuki; Franz von Ziegler; Theodore A Bass; Marco A Costa
Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant coronary artery disease.
American heart journal 2007;154(2):298-305.
2007: Pilar Jiménez-Quevedo; Manel Sabaté; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Marcelo Sanmartín; Joan Antoni Gómez-Hospital; Camino Bañuelos; Javier Escaned; Raúl Moreno; Cristina Fernández; Francisco Fernández-Avilés; Carlos Macaya
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
European heart journal 2007;28(16):1946-52.
2007: Dominick J Angiolillo; Fernando Alfonso
Clopidogrel-statin interaction: myth or reality?
Journal of the American College of Cardiology 2007;50(4):296-8.
2007: Raúl Moreno; Cristina Fernandez; Angel Sanchez-Recalde; Guillermo Galeote; Luis Calvo; Fernando Alfonso; Rosana Hernandez; Rosa Sánchez-Aquino; Dominick J Angiolillo; Sergio Villarreal; Carlos Macaya; Jose Lopez-Sendon
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.
European heart journal 2007;28(13):1583-91.
2007: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Fernando Alfonso; Carlos Macaya; Theodore A Bass; Marco A Costa
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
Journal of the American College of Cardiology 2007;49(14):1505-16.
2007: Dominick J Angiolillo
Antiplatelet therapy in type 2 diabetes mellitus.
Current opinion in endocrinology, diabetes, and obesity 2007;14(2):124-31.
2007: R Kawaguchi; Dominick J Angiolillo; Hideki Futamatsu; Nobuaki Suzuki; Theodore A Bass; Marco A Costa
Stent thrombosis in the era of drug eluting stents.
Minerva cardioangiologica 2007;55(2):199-211.
2007: Chris Pavlovic; Hideki Futamatsu; Dominick J Angiolillo; Luis A Guzman; norbert wilke; Daniel Siragusa; Peter Wludyka; Robert Percy; Martin Northrup; Theodore A Bass; Marco A Costa
Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial disease: a comparative study versus standard digital angiography.
The international journal of cardiovascular imaging 2007;23(2):225-32.
2007: Dominick J Angiolillo; Steven Shoemaker; Bhaloo Desai; Hang Yuan; Ronald K Charlton; Esther Bernardo; Martin Zenni; Luis A Guzman; Theodore A Bass; Marco A Costa
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
Circulation 2007;115(6):708-16.
2007: Hideki Futamatsu; norbert wilke; Chris Klassen; Dominick J Angiolillo; Nobuaki Suzuki; R Kawaguchi; Steven Shoemaker; Alan Siuciak; Theodore A Bass; Marco A Costa
Usefulness of cardiac magnetic resonance imaging for coronary artery disease detection.
Minerva cardioangiologica 2007;55(1):105-14.
2007: Nobuaki Suzuki; Dominick J Angiolillo; R Kawaguchi; Hideki Futamatsu; Theodore A Bass; Marco A Costa
Percutaneous coronary intervention of bifurcation coronary disease.
Minerva cardioangiologica 2007;55(1):57-71.
2007: Raúl Moreno; María J Perez-Vizcayno; Angel Sanchez-Recalde; Luis Calvo; Guillermo Galeote; Fernando Alfonso; Rosana Hernandez; Dominick J Angiolillo; Esteban Lopez de Sa; Carlos Macaya; José López-Sendón
The impact of previously occluded noninfarct vessels in patients with acute myocardial infarction.
The American journal of cardiology 2007;99(3):429-30.
2007: Marco A Costa; Manel Sabate; Rodolfo Staico; Fernando Alfonso; Ana C Seixas; Mariano Albertal; Arthur Crossman; Dominick J Angiolillo; Martin Zenni; J Eduardo Sousa; Carlos Macaya; Theodore A Bass
Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial.
American heart journal 2007;153(2):296.e1-7.
2007: Marco A Costa; Manel Sabaté; Dominick J Angiolillo; Paula Hu; Pilar Jimenez-Quevedo; Cecilia Corros; Fernando Alfonso; Rosana Hernandez-Antolin; Carlos Macaya; Theodore A Bass
Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(2):181-8.
2007: Dominick J Angiolillo
ADP receptor antagonism: what's in the pipeline?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7(6):423-32.
2007: Ugo Cavallari; Elisabetta Trabetti; Giovanni Malerba; Michele Biscuola; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Dominick J Angiolillo; Roberto Corrocher; Pier Franco Pignatti
Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
BMC medical genetics 2007;8():59.
2006: Esther Bernardo; Dominick J Angiolillo; Celia Ramírez; Ugo Cavallari; Elisabetta Trabetti; Manel Sabaté; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Pier Franco Pignatti; Carlos Macaya; Antonio Fernandez-Ortiz
Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease.
Platelets 2006;17(8):586-90.
2006: Dominick J Angiolillo
Tackling the diabetic platelet: is high clopidogrel dosing the answer?
Journal of thrombosis and haemostasis : JTH 2006;4(12):2563-5.
2006: Fernando Alfonso; Dominick J Angiolillo
Platelet function assessment to predict outcomes after coronary interventions: hype or hope?
Journal of the American College of Cardiology 2006;48(9):1751-4.
2006: Esther Bernardo; Dominick J Angiolillo; Celia Ramírez; Ugo Cavallari; Elisabetta Trabetti; Manel Sabaté; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Pier Franco Pignatti; Carlos Macaya; Antonio Fernandez-Ortiz
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
The American journal of cardiology 2006;98(9):1182-4.
2006: Pilar Jiménez-Quevedo; Manel Sabaté; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Joan Antoni Gómez-Hospital; Marcelo Sanmartín; Camino Bañuelos; Raúl Moreno; Javier Escaned; Cristina Fernández; Marco A Costa; Francisco Fernández-Avilés; Carlos Macaya
[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].
Revista española de cardiología 2006;59(10):1000-7.
2006: Hideki Futamatsu; Manel Sabaté; Dominick J Angiolillo; Pilar Jimenez-Quevedo; Cecilia Corros; Kino Morikawa-Futamatsu; Fernando Alfonso; Julie Jiang; Pavel Cervinka; Rosana Hernandez-Antolin; Carlos Macaya; Theodore A Bass; Marco A Costa
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
Journal of the American College of Cardiology 2006;48(6):1139-45.
2006: Silvia Gómez-Moreno; Manel Sabaté; Pilar Jiménez-Quevedo; Paul Vázquez; Fernando Alfonso; Dominick J Angiolillo; Rosana Hernández-Antolín; Raúl Moreno; Camino Bañuelos; Javier Escaned; Carlos Macaya
Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2006;2(2):197-202.
2006: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Ugo Cavallari; Elisabetta Trabetti; Manel Sabaté; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Pier Franco Pignatti; Carlos Macaya
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(8):1895-900.
2006: Dominick J Angiolillo; Esther Bernardo; Celia Ramírez; Marco A Costa; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Theodore A Bass; Carlos Macaya; Antonio Fernandez-Ortiz
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
Journal of the American College of Cardiology 2006;48(2):298-304.
2006: Pilar Jiménez-Quevedo; Manel Sabaté; Dominick J Angiolillo; Marco A Costa; Fernando Alfonso; Joan Antoni Gómez-Hospital; Rosana Hernández-Antolín; Camino Bañuelos; Javier Goicolea; Francisco Fernández-Avilés; Theodore A Bass; Javier Escaned; Raúl Moreno; Cristina Fernández; Carlos Macaya
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Journal of the American College of Cardiology 2006;47(11):2172-9.
2006: Dominick J Angiolillo; Debbie Singh
Clopidogrel for up to one year after PCI is cost-effective for people with acute coronary syndromes.
Evidence-based cardiovascular medicine 2006;10(2):116-8.
2006: Pavel Cervinka; Marco A Costa; Dominick J Angiolillo; Radim Spacek; Marian Bystron; Martin Kvasnák; Josef Veselka; Hitesh Nanda; Hideki Futamatsu; Kino Futamatsu
"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(6):846-51.
2006: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease.
Diabetes 2006;55(3):780-4.
2006: Marco A Costa; Manel Sabate; Dominick J Angiolillo; Pilar Jimenez-Quevedo; Paul Teirstein; Andrew Carter; Martin B Leon; Jeffrey Moses; Martin Zenni; Steven Yakubov; Luis A Guzman; Paul Gilmore; Carlos Macaya; Theodore A Bass
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.
The American journal of cardiology 2006;97(2):203-6.
2006: Raúl Moreno; Cesar Conde; María J Perez-Vizcayno; Sergio Villarreal; Rosana Hernandez-Antolin; Fernando Alfonso; Camino Bañuelos; Dominick J Angiolillo; Javier Escaned; Antonio Fernandez-Ortiz; Carlos Macaya
Prognostic impact of a chronic occlusion in a noninfarct vessel in patients with acute myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention.
The Journal of invasive cardiology 2006;18(1):16-9.
2006: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
The American journal of cardiology 2006;97(1):38-43.
2005: Pilar Jiménez-Quevedo; Manel Sabaté; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Camino Bañuelos; Esther Bernardo; Celia Ramirez; Raúl Moreno; Cristina Fernández; Javier Escaned; Carlos Macaya
LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study.
European heart journal 2005;26(21):2307-12.
2005: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Ugo Cavallari; Elisabetta Trabetti; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Pier Franco Pignatti; Carlos Macaya
Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene.
The American journal of cardiology 2005;96(8):1095-9.
2005: Manel Sabaté; Pilar Jiménez-Quevedo; Dominick J Angiolillo; Joan Antoni Gómez-Hospital; Fernando Alfonso; Rosana Hernández-Antolín; Javier Goicolea; Camino Bañuelos; Javier Escaned; Raúl Moreno; Cristina Fernández; Francisco Fernández-Avilés; Carlos Macaya
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Circulation 2005;112(14):2175-83.
2005: Marco Costa; Dominick J Angiolillo; Paul Teirstein; Paul Gilmore; Martin Leon; Jeffrey Moses; Steven Yakubov; Andrew Carter; Tim A Fischell; Martin Zenni; Theodore A Bass
Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.
The Journal of invasive cardiology 2005;17(8):396-8.
2005: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
Diabetes 2005;54(8):2430-5.
2005: Raúl Moreno; Julio Perez-Rodriguez; Maria-José Perez; Fernando Alfonso; Rosana Hernandez; Dominick J Angiolillo; Manel Sabaté; Camino Bañuelos; Javier Escaned; Luis Azcona; Carlos Macaya
Long-term outcome of patients with proximal left anterior descending coronary artery in-stent restenosis treated with a second percutaneous procedure.
The Journal of invasive cardiology 2005;17(4):218-21.
2005: Raúl Moreno; Cristina Fernández; Rosana Hernández; Fernando Alfonso; Dominick J Angiolillo; Manel Sabaté; Javier Escaned; Camino Bañuelos; Antonio Fernández-Ortiz; Carlos Macaya
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
Journal of the American College of Cardiology 2005;45(6):954-9.
2005: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Ugo Cavallari; Elisabetta Trabetti; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Pier Franco Pignatti; Carlos Macaya
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
Thrombosis research 2005;116(6):491-7.
2005: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Carlos Barrera-Ramirez; Manel Sabaté; Rosana Hernández; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Marco A Costa; Theodore A Bass; Carlos Macaya
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
Thrombosis research 2005;115(1-2):101-8.
2004: Mario A Pulido; Dominick J Angiolillo; Marco A Costa
Imaging of atherosclerotic plaque.
The international journal of cardiovascular imaging 2004;20(6):553-9.
2004: Pilar Jiménez-Quevedo; Manel Sabaté; Dominick J Angiolillo; Rosana Hernández-Antolín; Cristina Fernández; Cecilia Corros; Fernando Alfonso; Javier Escaned; Camino Bañuelos; Raúl Moreno; María J Pérez-Vizcayno; Carlos Macaya
[Predictors of mortality following rescue percutaneous intervention].
Revista española de cardiología 2004;57(12):1151-8.
2004: Fernando Alfonso; A Suárez; Dominick J Angiolillo; Manel Sabaté; Javier Escaned; Raúl Moreno; Rosana Hernández; Camino Bañuelos; Carlos Macaya
Findings of intravascular ultrasound during acute stent thrombosis.
Heart (British Cardiac Society) 2004;90(12):1455-9.
2004: Dominick J Angiolillo; Antonio Fernández-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Camino Bañuelos; Rosana Hernández-Antolín; Javier Escaned; Raúl Moreno; Fernando Alfonso; Carlos Macaya
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.
European heart journal 2004;25(21):1903-10.
2004: S Peykar; Dominick J Angiolillo; Theodore A Bass; Marco A Costa
Saphenous vein graft disease.
Minerva cardioangiologica 2004;52(5):379-90.
2004: Manel Sabaté; Gela Pimentel; Carlos Prieto; José María Corral; Camino Bañuelos; Dominick J Angiolillo; Fernando Alfonso; Rosana Hernández-Antolín; Javier Escaned; Panayotis Fantidis; Cristina Fernández; Antonio Fernández-Ortiz; Raúl Moreno; Carlos Macaya
Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound study.
Journal of the American College of Cardiology 2004;44(3):520-7.
2004: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Javier Escaned; Raúl Moreno; Rosana Hernández-Antolin; Manel Sabaté; Elisabetta Trabetti; Pier Franco Pignatti; Carlos Macaya
807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(5):427-33.
2004: Raúl Moreno; Cristina Fernández; Fernando Alfonso; Rosana Hernández; María J Pérez-Vizcayno; Javier Escaned; Manel Sabaté; Camino Bañuelos; Dominick J Angiolillo; Luis Azcona; Carlos Macaya
Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies.
Journal of the American College of Cardiology 2004;43(11):1964-72.
2004: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Celia Ramírez; Manel Sabaté; Rosana Hernández-Antolín; Raúl Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Carlos Macaya
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
The Journal of invasive cardiology 2004;16(6):325-9.
2004: Dominick J Angiolillo; Luigi M Biasucci; Giovanna Liuzzo; Filippo Crea
[Inflammation in acute coronary syndromes: mechanisms and clinical implications].
Revista española de cardiología 2004;57(5):433-46.
2004: Pilar Jiménez-Quevedo; Dominick J Angiolillo; Esther Bernardo; Manel Sabaté
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;62(1):39-42.
2004: Dominick J Angiolillo; Raúl Moreno; Carlos Macaya
Isolated distal coronary dissection in Marfan syndrome.
Italian heart journal : official journal of the Italian Federation of Cardiology 2004;5(4):305-6.
2004: Javier Martín de la Torre; Dominick J Angiolillo; Rosana Hernandez-Antolin; David R Ramsdale; John G Webb; James P Zidar; Larry J Diaz-Sandoval; Ik-Kyung Jang
Extensive thrombus of distal anastomosis of saphenous vein graft.
The Journal of invasive cardiology 2004;16(4):198-200.
2004: Dominick J Angiolillo; Antonio Fernández-Ortiz; Esther Bernardo; Carlos Felipe Barrera-Ramírez; Manel Sabaté; Cristina Fernandez; Rosana Hernández-Antolín; Javier Escaned; Fernando Alfonso; Carlos Macaya
Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?
The Journal of invasive cardiology 2004;16(4):169-74.
2004: Dominick J Angiolillo; Manel Sabatá; Fernando Alfonso; Carlos Macaya
"Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;61(3):387-91.
2004: Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Fernando Alfonso; Manel Sabaté; Cristina Fernández; Chiara Stranieri; Elisabetta Trabetti; Pier Franco Pignatti; Carlos Macaya
PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(1):89-93.
2003: Dominick J Angiolillo; Manel Sabaté; Pilar Jiménez-Quevedo; Fernando Alfonso; Carmen Galván; José Miguel Fernández; Rosana Hernandez-Antolin; Javier Escaned; Camino Bañuelos; Raúl Moreno; Carlos Macaya
Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!
Cardiovascular radiation medicine 2003;4(4):171-5.
2003: Dominick J Angiolillo; Manel Sabaté
[Past, present, and future of intracoronary brachytherapy].
Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 2003;4(10):794-806.
2003: Luigi M Biasucci; Giovanna Liuzzo; Alessandra Ciervo; Andrea Petrucca; Maddalena Piro; Dominick J Angiolillo; Filippo Crea; Antonio Cassone; Attilio Maseri
Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes.
Circulation 2003;107(24):3015-7.
2003: Dominick J Angiolillo; Manel Sabaté; Antonio Fernández-Ortiz; Carlos Macaya
Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb/IIIa antagonists: potential rebound prothrombotic effect?
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2003;58(4):481-4.
2003: Dominick J Angiolillo; Giovanna Liuzzo; Simona Pelliccioni; Erica De Candia; Raffaele Landolfi; Filippo Crea; Attilio Maseri; Luigi M Biasucci
Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina.
Journal of the American College of Cardiology 2003;41(4):546-50.
2002: Dominick J Angiolillo; Alessandro Giordano
Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: are low-risk patients really low?
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2002;9(5):550-3.
2002: Elisabetta Rossi; Luigi M Biasucci; Franco Citterio; Simona Pelliccioni; Claudia Monaco; Francesca Ginnetti; Dominick J Angiolillo; Gianni Grieco; Giovanna Liuzzo; Attilio Maseri
Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein.
Circulation 2002;105(7):800-3.
2001: Giovanna Liuzzo; Dominick J Angiolillo; Antonino Buffon; Vittoria Rizzello; C Colizzi; Francesca Ginnetti; Luigi M Biasucci; Attilio Maseri
Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina.
Circulation 2001;103(18):2236-41.
1999: C Colizzi; Vittoria Rizzello; Dominick J Angiolillo; Giovanna Liuzzo; Francesca Ginnetti; Claudia Monaco; Gianluca Comerci; G Vitrella; Attilio Maseri; Luigi M Biasucci
In vitro hyperreactivity to lipopolysaccharide in patients with history of unstable angina is not associated with seropositivity for Cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae.
Cardiologia (Rome, Italy) 1999;44(4):377-80.